NCT01610180 2018-07-16Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)Fondazione Progetto EmatologiaPhase 2 Completed18 enrolled